Pear Therapeutics, Inc.

SPAC M&A

Capital Markets Advisor, December 2021

Pear Therapeutics, Inc.
Business Combination with Thimble Point Acquisition Corp.

Pear Therapeutics, Inc. is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs).

More Like This

Nov 2022
OmniAb Logo

Closing of Business Combination with Avista Public Acquisition Corp. II (NASDAQ: AHPA)

Capital Markets Advisor

View Details >
Aug 2022

Business Combination with Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA)

Financial Advisor

View Details >
Oct 2021

Business Combination with Mountain Crest Acquisition Corp II

Exclusive Financial and Capital Markets Advisor

View Details >